2 articles featuring Pinene
Chemotherapy-induced nausea and vomiting (CINV) remains a primary driver of treatment non-compliance and reduced quality of life. Modern clinical standards are shifting. While traditional anti-emetics serve as the baseline, the $21 billion global supportive care market is increasingly incorporating cannabinoid therapeutics to fill efficacy gaps. Cannabis is now viewed as a strategic component of evidence-based supportive oncology.
'The munchies'—or clinically, hyperphagia—is a physiological response triggered when exogenous cannabinoids interact with your body’s endocannabinoid system (ECS). By binding to CB1 receptors in the hypothalamus and the olfactory bulb, specific cannabis compounds may influence how your brain perceives hunger, sensory pleasure, and metabolic homeostasis.